3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Leukemia, Myeloid, Acute
121
Precursor Cell Lymphoblastic Leukemia-Lymphoma
79
Leukemia, Lymphocytic, Chronic, B-Cell
65
Hematologic Neoplasms
62
Leukemia
52
Myelodysplastic Syndromes
47
Lymphoma
34
Lymphoma, Non-Hodgkin
28
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
28
Multiple Myeloma
20
Burkitt Lymphoma
20
Leukemia, Myelomonocytic, Chronic
19
Recurrence
18
Neoplasms
17
Lymphoma, Large B-Cell, Diffuse
15
Leukemia, B-Cell
14
Hodgkin Disease
14
Myeloproliferative Disorders
13
Lymphoma, Mantle-Cell
12
Lymphoma, Follicular
11
Leukemia, Biphenotypic, Acute
11
Waldenstrom Macroglobulinemia
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
10
Lymphoma, B-Cell, Marginal Zone
10
Lymphoma, B-Cell
10
Anemia, Refractory, with Excess of Blasts
10
Blast Crisis
8
Primary Myelofibrosis
7
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
6
Myelodysplastic-Myeloproliferative Diseases
6
Interventions
dolutegravir
1
Tenofovir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
HTLV-I Infections
×
Other hematologic neoplasm
×
30 days
×
Clear all
NCT07555431
2026-06-02
DOT-H
Fundação Bahiana de Infectologia
Phase 2
Recruiting
146 enrolled